Reuters exclusively reports White House preparing order that would cut drug prices for Medicare

Reuters exclusively reported that the White House is working on a sweeping executive order that would cut prices on virtually all branded prescription drugs sold to Medicare and other government programs. The order under discussion would be much broader than the Administration’s previously disclosed proposal to lower prices on physician administered, or Part B, drugs by tying prices to lower costs in other countries